Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry

Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registrySecondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry, Published online: 23 January 2018; doi:10.1038/s41409-018-0096-6Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry

Source: Bone Marrow Transplantation - January 23, 2018 Category: Hematology Authors: Ana Jim énez-Ubieto Carlos Grande Dolores Caballero Lucrecia Y áñez Miguel Teodoro Hern ández-Garcia Silvana Novelli Reyes Arranz Jos é Javier Ferreiro Sabella Bobillo Santiago Mercadal Andrea Galeo Javier L ópez Jiménez Jos é María Moraleda Carl Source Type: research